Cargando…

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

Soft tissue sarcomas are rare tumours with infrequent identified aetiological factors. Several genetic syndromes as well as previous radiation therapy and/or chronic lymphoedema have been suspected to predispose to some soft tissue sarcomas. Between January 1997 and September 2005, we carried out a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Penel, Nicolas, Grosjean, Jessica, Robin, Yves Marie, Vanseymortier, Luc, Clisant, Stéphanie, Adenis, Antoine
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386887/ https://www.ncbi.nlm.nih.gov/pubmed/18497869 http://dx.doi.org/10.1155/2008/459386

Ejemplares similares

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
por: Brodowicz, Thomas, et al.
Publicado: (2015)

Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials
por: Kotecki, Nuria, et al.
Publicado: (2012)

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study
por: Ligier, Karine, et al.
Publicado: (2015)

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis
por: Berry, Vincent, et al.
Publicado: (2017)

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO)
por: Lebellec, Loic, et al.
Publicado: (2016)

The evolutionary history of 2,658 cancers
por: Gerstung, Moritz, et al.
Publicado: (2020)

High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue Sarcomas
por: Groothuis, Patrick, et al.
Publicado: (2021)

Adjuvant radiation therapy in metastatic lymph nodes from melanoma
por: Bibault, Jean-Emmanuel, et al.
Publicado: (2011)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial
por: Pannier, Diane, et al.
Publicado: (2018)

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review
por: Sharma, Sheetal, et al.
Publicado: (2013)

Pharmacogenetic Study of Trabectedin-Induced Severe Hepatotoxicity in Patients with Advanced Soft Tissue Sarcoma
por: Maillard, Maud, et al.
Publicado: (2020)

Colección teatro-vol. 401 al vol. 658
Publicado: (1964)

Author Correction: The evolutionary history of 2,658 cancers
por: Gerstung, Moritz, et al.
Publicado: (2023)

A massive quiescent galaxy at redshift 4.658
por: Carnall, Adam C., et al.
Publicado: (2023)

Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism
por: Jannin, Arnaud, et al.
Publicado: (2017)

Descriptive epidemiology of soft tissue and bone sarcomas in Lebanon
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care
por: Penel, N, et al.
Publicado: (2010)

Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published Trials
por: Cren, Pierre-Yves, et al.
Publicado: (2020)

Assessing Prognostic and Predictive Biomarkers of Regorafenib Response in Patients with Advanced Soft Tissue Sarcoma: REGOSARC Study
por: Brodowicz, Thomas, et al.
Publicado: (2020)

Shortening the Time Interval for the Referral of Patients With Soft Tissue Sarcoma to Expert Centers Using Mobile Health: Retrospective Study
por: Nannini, Simon, et al.
Publicado: (2022)

Establishing an RNA fusions panel in soft tissue sarcoma with clinical validation
por: Huang, Xiaoqiang, et al.
Publicado: (2023)

The off-label use of targeted therapies in sarcomas: the OUTC’S program
por: Eberst, Lauriane, et al.
Publicado: (2014)

circNFIC suppresses breast cancer progression by sponging miR-658
por: Xu, Gaosheng, et al.
Publicado: (2020)

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
por: Rheinbay, Esther, et al.
Publicado: (2020)

Genome Sequence and Evaluation of Safety and Probiotic Potential of Lactiplantibacillus plantarum LPJZ-658
por: Deng, Liquan, et al.
Publicado: (2023)

FRI658 Diabetic Ketoacidosis Masked By Cannabis In Type 2 Diabetes Mellitus
por: Bosques-Lorenzo, Jaymilitte, et al.
Publicado: (2023)

Descriptive epidemiology of soft tissue sarcomas and gastrointestinal stromal tumors in Thailand
por: Klangjorhor, Jeerawan, et al.
Publicado: (2022)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
por: Salawu, Abdulazeez, et al.
Publicado: (2016)

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
por: Adenis, Antoine, et al.
Publicado: (2013)

658. Trends in Mumps Cases and Incidence, United States, January 2016‒April 2018
por: Clemmons, Nakia, et al.
Publicado: (2018)

Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
por: Cortés-Ciriano, Isidro, et al.
Publicado: (2020)

SAT-658 Associations of Serum and CSF Kisspeptin Levels with Metabolic and Reproductive Parameters in Men
por: Mutirangura, Pornthira, et al.
Publicado: (2020)

Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
por: Dentro, Stefan C., et al.
Publicado: (2021)

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study
por: Penel, N, et al.
Publicado: (2011)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

Remarks on Certain Diseases of the Nails and the Surrounding Soft Parts
por: Burnett, G. T.
Publicado: (1829)

Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research
por: Lee, Che-Jui, et al.
Publicado: (2021)

The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
por: Figlioli, Gisella, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hr19ci3a7t0o078r7t9lnu12rc